Added by | standudu |
---|---|
Group name | EquipeCTCS |
Item Type | Attachment |
Title | Texte intégral |
URL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300571/pdf/main.pdf |
Accessed | 2023/10/16 - 18:51:28 |
Date Added | 2023/10/16 - 16:51:28 |
Date Modified | 2023/10/16 - 16:51:28 |
Parent item | Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases |